August 14, 2020
Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice BookmarkGeorge Lundberg, MD
Research paper from the Journal of Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes:
Safety and potential adverse effects are serious issues with many cancer treatments. This academic paper outlines post-marketing research that reveals few adverse effects from a type of treatment known as tumor-treating fields (TTF) in brain malignancies.
Go to full paper published in the Journal of Neuro-Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.